Abstract
Primary cutaneous anaplastic large cell lymphoma (pcALCL), a member of the spectrum of CD30+ lymphoproliferative diseases, has an excellent prognosis. This indolent lymphoma is the second most common of all cutaneous T-cell lymphomas. It typically presents with solitary cutaneous and subcutaneous erythematous-to-violaceous papules and nodules. Although relapse after treatment is very common, patients are typically asymptomatic, and the vast majority do not experience extracutaneous spread.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Liu HL, Hoppe RT, Kohler S, Harvell JD, Reddy S, Kim YH. CD30+ cutaneous lymphoproliferative disorders: the Stanford experience in lymphomatoid papulosis and primary cutaneous anaplastic large cell lymphoma. J Am Acad Dermatol. 2003;49:1049–58.
Ralfkiaer E, Willemze R, Paulli M, Kadin ME, et al. Primary cutaneous CD30-positive T-cell lymphoproliferative disorders. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al., editors. WHO classification of tumors of hematopoietic and lymphoid tissues. Lyon: International Agency for Research on Cancer; 2008. p. 300–1.
Bekkenk MW, Geelen AMJ, Vader PCVV, Heule F, Geerts M, van Vloten WA, et al. Primary and secondary cutaneous CD30 lymphoproliferative disorders: a report from the Dutch Cutaneous Lymphoma Group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatment. Blood. 2000;95:3653–61.
Beljaards RC, Kaudewitz P, Berti E, Gianotti R, Neumann C, Rosso R, et al. Primary cutaneous CD30-positive large cell lymphoma: definition of a new type of cutaneous lymphoma with a favorable prognosis. A European Multicenter Study of 47 patients. Cancer. 1993;71:2097–104.
Berge RL, Oudejans JJ, Ossenkoppele GJ, Pulford K, Willemze R, Falini B, et al. ALK expression in extranodal anaplastic large cell lymphoma favours systemic disease with (primary) nodal involvement and a good prognosis and occurs before dissemination. J Clin Pathol. 2000;53:445–50.
Savage KJ, Harris NL, Vose JM, Ullrich F, Jaffe ES, Connors JM, et al. ALK- anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project. Blood. 2008;111:5496–504.
Stein H, Foss H, Dürkop H, Marafioti T, Delsol G, Pulford K, et al. Review article. CD30(+) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features. Blood. 2013;96(12):3681–95.
Drews R, Samel A, Kadin ME. Lymphomatoid papulosis and anaplastic large cell lymphomas of the skin. Semin Cutan Med Surg. 2000;19:109–17.
Shehan JM, Kalaaji AN, Markovic SN, Ahmed I. Management of multifocal primary cutaneous CD30 anaplastic large cell lymphoma. J Am Acad Dermatol. 2004;51:103–10.
Yu JB, McNiff JM, Lund MW, Wilson LD. Treatment of primary cutaneous CD30+ anaplastic large-cell lymphoma with radiation therapy. Int J Radiat Oncol Biol Phys. 2008;70:1542–5.
Blume JE, Stoll HL, Cheney RT. Treatment of primary cutaneous CD30+ anaplastic large cell lymphoma with intralesional methotrexate. J Am Acad Dermatol. 2006;54:S229–30.
Oliveira A, Fernandes I, Alves R, Lima M, Selores M. Primary cutaneous CD30 positive anaplastic large cell lymphoma – report of a case treated with bexarotene. Leuk Res. 2011;35:e190–2.
Kutok JL. Molecular biology of anaplastic lymphoma kinase-positive anaplastic large-cell lymphoma. J Clin Oncol. 2002;20:3691–702.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Goyal, A., Carter, J.B., Barnes, J.A., LeBoeuf, N.R., Duncan, L.M. (2015). CD30+ Primary Cutaneous Anaplastic Large Cell Lymphoma. In: Carter, J., Goyal, A., McDivitt Duncan, L. (eds) Atlas of Cutaneous Lymphomas. Springer, Cham. https://doi.org/10.1007/978-3-319-17217-0_10
Download citation
DOI: https://doi.org/10.1007/978-3-319-17217-0_10
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-17216-3
Online ISBN: 978-3-319-17217-0
eBook Packages: MedicineMedicine (R0)